Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.

<h4>Background</h4>China's national tuberculosis programme does not have cohort wise information regarding attrition and delays in the multidrug resistant tuberculosis (MDR-TB) diagnosis and treatment pathway.<h4>Objective</h4>Under the Global Fund programmatic managemen...

Full description

Bibliographic Details
Main Authors: Caihong Xu, Renzhong Li, Hemant Deepak Shewade, Kathiresan Jeyashree, Yunzhou Ruan, Canyou Zhang, Lixia Wang, Hui Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0214943